Please login to the form below

Not currently logged in
Email:
Password:

Editas Medicine

This page shows the latest Editas Medicine news and features for those working in and with pharma, biotech and healthcare.

Bayer forms JV with gene editing firm CRISPR

Bayer forms JV with gene editing firm CRISPR

CRISPR was formed by a team led by Emmanuelle Charpentier, who was awarded the Janssen Award for Biomedical Research last year - along with Jennifer Doudna of Editas Medicine - for the discovery

Latest news

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2017 Deal Watch March 2017

    Editas Medicine has entered a strategic R&D alliance where Allergan has exclusive access to Editas’s CRISPR genome-editing programmes in ocular health, as well as options to license up ... 100. Editas. Allergan. R&D alliance. LCA10 and up to four other

  • Deal Watch May 2016 Deal Watch May 2016

    This follows the $94m IPO of Editas Medicine in February this year.

  • Deal Watch October 2015 Deal Watch October 2015

    companies. Other biotechs exploiting the CRISPR/Cas-9 technology for the development of therapeutics include Editas Medicine, Intellia Therapeutics and Caribou Biosciences; both Novartis and AstraZeneca have already developed collaborations in

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Editas Medicine names James Mullen as chairman Editas Medicine names James Mullen as chairman

    Editas Medicine names James Mullen as chairman. He has previously served as CEO of Patheon. ... Genome editing company Editas Medicine has appointed James Mullen as chairman of the board of directors.

  • Editas Medicine adds to its board of directors Editas Medicine adds to its board of directors

    Editas Medicine adds to its board of directors. Jessica Hopfield will also serve on the genome editing firm's audit committee. ... She said: “I am honoured to join Editas Medicine’s board of directors. “

  • Editas Medicine adds to board of directors Editas Medicine adds to board of directors

    Editas Medicine adds to board of directors. Alnylam Pharmaceuticals’ Dr Akshay Vaishnaw joins. ... Cambridge, Massachusetts-based Editas Medicine has appointed Dr Akshay Vaishnaw to its board of directors.

More from appointments
Approximately 3 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics